SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513523.
  • 2
    Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard MJ, Olsen BR, Warman ML 1996 Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12–13. Am J Hum Genet 59: 146151.
  • 3
    Little RD, Carulli JP, Del M, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 1119.
  • 4
    Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 15131521.
  • 5
    Boyden LM, Insogna K, Lifton RP 2004 High-bone-mass disease and LRP5 (author's reply). N Engl J Med 350: 20962099.
  • 6
    Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W 2003 Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72: 763771.
  • 7
    Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet J-P, He X 2000 LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530535.
  • 8
    Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S 2000 Arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature 407: 527530.
  • 9
    Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303314.
  • 10
    Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960974.
  • 11
    Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, Zheng J, Li L, Harris S, Wu D 2004 The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol 24: 46774684.
  • 12
    Ai M, Schelling D, Warman ML 2004 OPPG and HBM disease-causing missense mutations in LRP5 have opposite effects on Wnt signaling. J Bone Miner Res 19: S1S80.
  • 13
    Wilkie AO 1997 Craniosynostosis: Genes and mechanisms. Hum Mol Genet 6: 16471656.
  • 14
    Kabbani H, Raghuveer TS 2004 Craniosynostosis. Am Fam Physician 69: 28632870.
  • 15
    Brouwer OH 1970 Een Bijzondere Vorm van Osteosclerose. Proefschrift Leiden. Mouton & Co., 's-Gravenhage, The Netherlands.
  • 16
    Benichou OD, Laredo JD, de Vernejoul MC 2000 Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): Clinical and radiological manifestations in 42 patients. Bone 26: 8793.
  • 17
    Whyte MP, Reinus WH, Mumm S 2004 High-bone-mass disease and LRP5. N Engl J Med 350: 20962098.
  • 18
    Beals RK, McLoughlin SW, Teed RL, McDonald C 2001 Dominant endosteal hyperostosis: Skeletal characteristics and review of the literature. J Bone Joint Surg Am 83: 16431649.
  • 19
    Friede H, Manaligod JR, Rosenthal IM 1985 Craniofacial abnormalities in osteopetrosis with precocious manifestations: Report of a case with serial cephalometric roentgenograms. J Craniofac Genet Dev Biol 5: 247257.
  • 20
    Krimmel M, Niemann G, Will B, Reinert S 2004 Surgical correction of craniosynostosis in malignant osteopetrosis. J Craniofac Surg 15: 218221.
  • 21
    Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, Majnemer A, Noetzel M, Sheth RD 2003 Practice parameter: Evaluation of the child with global developmental delay. Neurology 60: 367380.
  • 22
    Panchal J, Amirsheybani H, Gurwitch R, Cook V, Francel P, Neas B, Levine N 2001 Neurodevelopment in children with single-suture craniosynostosis and plagiocephaly without synostosis. Plast Reconstr Surg 108: 14921498.
  • 23
    Cohen SR, Cho DC, Nichols SL, Simms C, Cross KP, Burstein FD 2004 American society of maxillofacial surgeons outcome study: Preoperative and postoperative neurodevelopmental findings in single-suture craniosynostosis. Plast Reconstr Surg 114: 841847.
  • 24
    Speltz ML, Kapp-Simon KA, Cunningham M, Marsh J, Dawson G 2004 Single-suture craniosynostosis: A review of neurobehavioral research and theory. J Pediatr Psychol 29: 651668.